Lyophilisation, commonly known as freeze-drying, plays a pivotal role in the field of biopharmaceutics, revolutionizing the preservation of sensitive biological materials. This sophisticated process involves freezing a substance and then removing the frozen solvent through sublimation, resulting in a stable, dry product with an extended shelf life.
In biopharmaceutics, lyophilisation is instrumental in preserving the integrity of delicate biomolecules such as proteins, enzymes, and vaccines. This method mitigates the risks of degradation and maintains the bioactivity of these substances, ensuring their efficacy upon reconstitution. The versatility of lyophilisation makes it an indispensable tool in pharmaceuticals, allowing for the development of injectable drugs, oral tablets, and other dosage forms.
Beyond stability, lyophilisation addresses challenges associated with transportation and storage, particularly for biopharmaceuticals that require stringent temperature control. This process facilitates the creation of lightweight, transportable formulations without compromising the therapeutic potential of the drug.
Submit your abstract Today
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation